| 000 | 01926 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514220921.0 | ||
| 264 | 0 | _c20050512 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a1473-0502 | ||
| 024 | 7 |
_a10.1016/j.transci.2004.10.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWessels, Glynn | |
| 245 | 0 | 0 |
_aPerspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa. _h[electronic resource] |
| 260 |
_bTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis _cFeb 2005 |
||
| 300 |
_a27-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 | _aBlood Transfusion |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDacarbazine _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aHodgkin Disease _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xtherapy |
| 650 | 0 | 4 |
_aMechlorethamine _xadministration & dosage |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 |
_aProcarbazine _xadministration & dosage |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSouth Africa |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aBernard Hesseling, Peter | |
| 773 | 0 |
_tTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis _gvol. 32 _gno. 1 _gp. 27-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transci.2004.10.003 _zAvailable from publisher's website |
| 999 |
_c15412041 _d15412041 |
||